Scambia G - Search Results

1

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial.

Vergote I, Scambia G, O'Malley DM, Van Calster B, Park SY, Del Campo JM, Meier W, Bamias A, Colombo N, Wenham RM, Covens A, Marth C, Raza Mirza M, Kroep JR, Ma H, Pickett CA, Monk BJ; TRINOVA-3/ENGOT-ov2/GOG-3001 investigators. Vergote I, et al. Among authors: scambia g. Lancet Oncol. 2019 Jun;20(6):862-876. doi: 10.1016/S1470-2045(19)30178-0. Epub 2019 May 7. Lancet Oncol. 2019. PMID: 31076365 Free article. Clinical Trial.

2

Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer.

D'Agostino G, Ferrandina G, Garganese G, Salerno MG, Lorusso D, Farnetano MG, Mancuso S, Scambia G. D'Agostino G, et al. Among authors: scambia g. Oncology. 2002;62(2):110-4. doi: 10.1159/000048255. Oncology. 2002. PMID: 11914595 Clinical Trial.

3

Gynecological malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study.

Ceccaroni M, D'Agostino G, Ferrandina G, Gadducci A, Di Vagno G, Pignata S, Poerio A, Salerno MG, Fanucchi A, Lapresa MT, Tambaro R, Scambia G. Ceccaroni M, et al. Among authors: scambia g. Gynecol Oncol. 2002 Jun;85(3):445-50. doi: 10.1006/gyno.2002.6631. Gynecol Oncol. 2002. PMID: 12051872

4

Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer.

D'Agostino G, Amant F, Berteloot P, Scambia G, Vergote I. D'Agostino G, et al. Among authors: scambia g. Gynecol Oncol. 2003 Mar;88(3):266-9. doi: 10.1016/s0090-8258(03)00011-8. Gynecol Oncol. 2003. PMID: 12648573 Clinical Trial.

5

Gemcitabine: current role and future options in the treatment of ovarian cancer.

Fruscella E, Gallo D, Ferrandina G, D'Agostino G, Scambia G. Fruscella E, et al. Among authors: scambia g. Crit Rev Oncol Hematol. 2003 Oct;48(1):81-8. doi: 10.1016/s1040-8428(03)00119-7. Crit Rev Oncol Hematol. 2003. PMID: 14585485 Review.

6

Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO stage IIIc ovarian cancer patients.

Fanfani F, Ferrandina G, Corrado G, Fagotti A, Zakut HV, Mancuso S, Scambia G. Fanfani F, et al. Among authors: scambia g. Oncology. 2003;65(4):316-22. doi: 10.1159/000074644. Oncology. 2003. PMID: 14707451

7

Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study.

De Placido S, Scambia G, Di Vagno G, Naglieri E, Lombardi AV, Biamonte R, Marinaccio M, Cartenì G, Manzione L, Febbraro A, De Matteis A, Gasparini G, Valerio MR, Danese S, Perrone F, Lauria R, De Laurentiis M, Greggi S, Gallo C, Pignata S. De Placido S, et al. Among authors: scambia g. J Clin Oncol. 2004 Jul 1;22(13):2635-42. doi: 10.1200/JCO.2004.09.088. J Clin Oncol. 2004. PMID: 15226331 Clinical Trial.

8

Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility.

Distefano M, Ferrandina G, Smaniotto D, Margariti AP, Zannoni G, Macchia G, Manfredi R, Mangiacotti MG, Cellini N, Scambia G. Distefano M, et al. Among authors: scambia g. Oncology. 2004;67(2):103-11. doi: 10.1159/000080995. Oncology. 2004. PMID: 15539913

9

Management of an advanced ovarian cancer at 15 weeks of gestation: case report and literature review.

Ferrandina G, Distefano M, Testa A, De Vincenzo R, Scambia G. Ferrandina G, et al. Among authors: scambia g. Gynecol Oncol. 2005 May;97(2):693-6. doi: 10.1016/j.ygyno.2005.02.011. Gynecol Oncol. 2005. PMID: 15863184 Review.

10

Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: updated results and long-term survival.

Ferrandina G, Paris I, Ludovisi M, D'Agostino G, Testa A, Lorusso D, Zanghi M, Pisconti S, Pezzella G, Adamo V, Breda E, Scambia G. Ferrandina G, et al. Among authors: scambia g. Gynecol Oncol. 2005 Aug;98(2):267-73. doi: 10.1016/j.ygyno.2005.04.018. Gynecol Oncol. 2005. PMID: 15975643 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,057 results

Search Page

Filters